Ionis Pharmaceuticals IONS Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's common stock shares issued?
- Ionis Pharmaceuticals (IONS) reported common stock shares issued of 165.9M in Q1 2026.
- How has Ionis Pharmaceuticals's common stock shares issued changed year-over-year?
- Ionis Pharmaceuticals's common stock shares issued increased by 4.3% year-over-year, from 159M to 165.9M.
- What is the long-term trend for Ionis Pharmaceuticals's common stock shares issued?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's common stock shares issued has grown at a 3.1% compound annual growth rate (CAGR), from 140.4M to 163.3M.
- What does common stock shares issued mean?
- The total number of shares of stock that have been created and distributed.
- How do you interpret common stock shares issued?
- An increase indicates share dilution, which may occur due to secondary offerings or stock-based compensation, potentially impacting shareholder value.
- How does common stock shares issued compare across companies?
- Standardized metric used to compare ownership structure and dilution across the industry.